Distinct evolutionary trajectories following loss of RNA interference in Cryptococcus neoformans
Proceedings of the National Academy of Sciences · 19.11.2024 · 121 (47)
DOI: 10.1073/pnas.2416656121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.11.2024. Verfasst von Jun Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710. Hauptthemen laut MEDLINE: Cryptococcus neoformans, RNA Interference. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
While increased mutation rates typically have negative consequences in multicellular organisms, hypermutation can be advantageous for microbes adapting to the environment. Previously, we identified two hypermutator Cryptococcus neoformans clinical isolates that rapidly develop drug resistance due to transposition of a retrotransposon, Cnl1. Cnl1-mediated hypermutation is caused by a nonsense mutation in a gene encoding an RNA interference (RNAi) component, ZNF3 , combined with a tremendous transposon burden. To elucidate adaptive mechanisms following RNAi loss, two bioinformatic pipelines were developed to identify RNAi loss-of-function (LOF) mutations in a collection of 387 sequenced C. neoformans isolates. Remarkably, several RNAi-loss isolates were identified that are not hypermutators and have not accumulated transposons. To test whether these RNAi LOF mutations can cause hypermutation, the mutations were introduced into a nonhypermutator strain with a high transposon burden, which resulted in a hypermutator phenotype. To further investigate whether RNAi-loss isolates can become hypermutators, in vitro passaging was performed. Although no hypermutators were found in two C. neoformans RNAi-loss strains after short-term passage, hypermutation was observed in a passaged Cryptococcus deneoformans strain with an increased transposon burden. Consistent with a two-step evolution, when an RNAi-loss isolate was crossed with an isolate containing a high Cnl1 burden, F1 hypermutator progeny inheriting a high transposon burden were identified. In addition to Cnl1 transpositions, insertions of a gigantic DNA transposon KDZ1 (~11 kb) contributed to hypermutation in the progeny. Our results suggest that RNAi loss is relatively common (7/387, ~1.8%) and enables distinct evolutionary trajectories: hypermutation following transposon accumulation or survival without hypermutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
- Department of Biology, Duke University, Durham, NC 27710.
ORCID-Profile: Jun Huang, Vikas Yadav, Paul M Magwene, Sheng Sun, Joseph Heitman
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Huang, J., Larmore, C. J., Priest, S. J., Xu, Z., Dietrich, F. S., Yadav, V., Magwene, P. M., Sun, S., & Heitman, J. (2024). Distinct evolutionary trajectories following loss of RNA interference in Cryptococcus neoformans. Proceedings of the National Academy of Sciences, 121(47). https://doi.org/10.1073/pnas.2416656121
Vancouver
Huang J, Larmore CJ, Priest SJ, Xu Z, Dietrich FS, Yadav V, et al. Distinct evolutionary trajectories following loss of RNA interference in Cryptococcus neoformans. Proceedings of the National Academy of Sciences. 2024;121(47). doi:10.1073/pnas.2416656121
BibTeX
@article{Huang2024,
author = {Huang, Jun and Larmore, Connor J and Priest, Shelby J and Xu, Ziyan and Dietrich, Fred S and Yadav, Vikas and Magwene, Paul M and Sun, Sheng and Heitman, Joseph},
title = {Distinct evolutionary trajectories following loss of RNA interference in Cryptococcus neoformans},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {47},
doi = {10.1073/pnas.2416656121}
}
EUVIMED